Dendreon

E1979946 UNEXPLORED

Dendreon is a biotechnology company best known for developing Provenge, an FDA-approved autologous cellular immunotherapy for advanced prostate cancer.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
Dendreon canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Valeant Pharmaceuticals → acquired → Dendreon ⓘ